The Linkages Between Reimbursement and Prevention: A Mixed-Methods Approach [PDF]
Frontiers in Public Health, 2021 Background: The benefits of prevention are widely recognized; ranging from avoiding disease onset to substantially reducing disease burden, which is especially relevant considering the increasing prevalence of chronic diseases.
Ellen Zwaagstra Salvado +3 more
doaj +3 more sources
Measurement of the Capitation-based Reimbursement Standard for Chronic Disease Management in Primary Care Clinics [PDF]
Zhongguo quanke yixue, 2023 Background The reimbursement of outpatient services is an essential part of the reform of medical insurance payment methods. With the comprehensive promotion of the reform on the medical insurance payment methods for inpatient services in China, the ...
NI Jianxiao, GAO Guangying, ZHAO Ning, LI Jin, XU Jiajie, WU Nina, YANG Jia
doaj +2 more sources
Incentive Compatible Reimbursement Schemes for Physicians [PDF]
SSRN Electronic Journal, 2010 Physicians choose capacity before demand materializes; actual demand may be higher or lower than capacity. If a physicians capacity exceeds demand, she may have an incentive to overtreat, i.e., she may provide unnecessary treatments to use up idle capacity.
Emons, Winand
core +8 more sources
Financial reimbursement incentives in the use of biosimilars for rheumatoid arthritis in Japan [PDF]
Journal of Pharmaceutical Policy and PracticeBackground Biosimilars present a significant opportunity for cost savings. However, the uptake of biosimilars has been inconsistent across different regions and drugs, highlighting the need for effective policy interventions.
Hiroaki Mamiya +2 more
doaj +2 more sources
The complex price setting and reimbursement of non-industrial advanced therapy medicinal products [PDF]
Health Economics ReviewBackground Advanced Therapy Medicinal Products (ATMPs) developed under the Hospital Exemption (HE) offer innovative treatments for patients with unmet medical needs, but their pricing and reimbursement (P&R) remain fragmented and poorly understood.
Zuzana Špacírová +2 more
doaj +2 more sources
Financial incentives for generic drugs: case study on a reimbursement program [PDF]
Einstein (São Paulo), 2010 Objective: To discuss the use of financial incentives in choice of medication and to assess the economic results concerning the use of financial incentives to promote the use of genetic medication in lieu of reference drugs in a company with a ...
Marcos Inocencio +3 more
doaj +8 more sources
Pricing and reimbursement of orphan drugs: the need for more transparency [PDF]
Orphanet Journal of Rare Diseases, 2011 Pricing and reimbursement of orphan drugs are an issue of high priority for policy makers, legislators, health care professionals, industry leaders, academics and patients.
Simoens Steven
doaj +2 more sources
Digital health technologies and stakeholder incentives in type-2 diabetes prevention [PDF]
Digital HealthBackground Type-2 diabetes (T2D) is largely preventable through sustained lifestyle change, yet healthcare systems face challenges in implementing and sustaining lifestyle interventions at scale.
Wasu Mekniran +5 more
doaj +2 more sources
Reimbursement Incentives for Hospital Care [PDF]
Annual Review of Public Health, 1986 The open-ended reimbursement of hospitals, physicians, and other providers by the government and by private third party payors has played a major role in the increasing costs of health care as well as the types and amounts of health care received by the American public.
J P, Bunker, R W, Schaffarzick
openaire +3 more sources
Financial Models for an Academic Practice in Plastic Surgery
Plastic and Reconstructive Surgery, Global Open, 2023 Background:. In an attempt to investigate physician compensation in academic practice, financial reimbursement models of departments and/or divisions of plastic surgery within an academic university setting were evaluated. Method:.
Kathrina Munoz, MHA +1 more
doaj +1 more source